Streptococcal Vaccine
Mostrando 1-12 de 57 artigos, teses e dissertações.
-
1. Streptococcal acute pharyngitis
Acute pharyngitis/tonsillitis, which is characterized by inflammation of the posterior pharynx and tonsils, is a common disease. Several viruses and bacteria can cause acute pharyngitis; however, Streptococcus pyogenes (also known as Lancefield group A β-hemolytic streptococci) is the only agent that requires an etiologic diagnosis and specific treatment. S
Rev. Soc. Bras. Med. Trop.. Publicado em: 2014-08
-
2. Avaliação de potencial agente vacinal contra o S.pyogenes em camundongos transgênicos, portadores de genes HLA de classe II humanos / Evaluation of potential vaccinal agent against s. pyogenes in human HLA class II transgenics mice
A faringite estreptocócica desencadeada pelo Streptococcus pyogenes pode resultar em uma série de doenças humanas e complicações como a febre reumática (FR) em indivíduos predispostos não tratados. A FR é uma doença autoimune que afeta mais de 20 milhões de crianças em países em desenvolvimento. A proteína M presente na membrana do S. pyogenes
IBICT - Instituto Brasileiro de Informação em Ciência e Tecnologia. Publicado em: 29/08/2011
-
3. Production and evaluation of autogenous bacterin against streptococcal meningitis in swine / Produção e avaliação de bacterina autógena contra meningite estreptococcica em suínos
The present work was developed with the objective to determine the efficiency of an autogenous bacterin against Streptococcus suis serotype 2 and to test route and inoculation doses. Two experiments were accomplished with 64 animals in each experiment. In the Experiment I, 32 animals were vaccinated and 32 animals received placebo, being both groups challeng
Publicado em: 2003
-
4. Immune Response of Rats to Group A Streptococcal Vaccine
Adult female Sprague-Dawley rats were hyperimmunized with group A streptococcal vaccine in an attempt to evaluate this species for its immunological responsiveness to the group A streptococcal carbohydrate. Pronounced hyperproteinemia, generally attributable to hypergammaglobulinemia was produced in 30 to 40% of the animals. The immune response of the rats w
-
5. TYPE-SPECIFIC STREPTOCOCCAL IMMUNIZATION WITH ORAL VACCINE
-
6. Erythrocyte antinuclear antibodies in sera of chickens hyperimmunized with group A streptococcal vaccine.
Chickens hyperimmunized with group A streptococcal vaccine often synthesize high levels of antibody to group A streptococcal carbohydrate (SACHO). Indirect immunofluorescent analysis revealed that sera of these chickens also contain antinuclear antibodies capable of reacting with chicken erythrocyte nuclei (EANA) at titers up to 2,560. Removal of the anti-SA
-
7. Intranasal Immunization with Multivalent Group A Streptococcal Vaccines Protects Mice against Intranasal Challenge Infections
We have previously shown that a hexavalent group A streptococcal M protein-based vaccine evoked bactericidal antibodies after intramuscular injection. In the present study, we show that the hexavalent vaccine formulated with several different mucosal adjuvants and delivered intranasally induced serum and salivary antibodies that protected mice from intranasa
American Society for Microbiology.
-
8. Protective Study with a Group A Streptococcal M Protein Vaccine. INFECTIVITY CHALLENGE OF HUMAN VOLUNTEERS
Healthy adult male volunteers were immunized with purified M protein from Group A streptococci. Type 1. The vaccine was administered subcutaneously as an aluminum hydroxide-precipitated antigen in three montly doses. Control subjects received a placebo of the aluminum hydroxide adjuvant. To test the efficacy of the immunization, vaccinees and controls were c
-
9. Pathogenesis of Group A Streptococcal Infections
Group A streptococci are model extracellular gram-positive pathogens responsible for pharyngitis, impetigo, rheumatic fever, and acute glomerulonephritis. A resurgence of invasive streptococcal diseases and rheumatic fever has appeared in outbreaks over the past 10 years, with a predominant M1 serotype as well as others identified with the outbreaks. emm (M
American Society for Microbiology.
-
10. Immunogenicity of group B Streptococcus type III polysaccharide-tetanus toxoid vaccine in baboons.
Maternal vaccination has been proposed as a rational approach for the prevention of neonatal group B streptococcal (GBS) disease. In this study, baboons were used as a nonhuman primate model to evaluate the immunogenicity of a GBS type III glycoconjugate vaccine. Type III-specific immunoglobulin G with opsonic activity was induced after vaccination with type
-
11. Immunization with FimA protects against Streptococcus parasanguis endocarditis in rats.
FimA, a surface-associated protein of Streptococcus parasanguis, is associated with initial colonization of damaged heart tissue in an endocarditis model (D. Burnette-Curley, V. Wells, H. Viscount, C. Munro, J. Fenno, P. Fives-Taylor, and F. Macrina, Infect. Immun. 63:4669-4674, 1995). We have evaluated the efficacy of recombinant FimA as a vaccine in the ra
-
12. Expression of streptococcal M protein in mammalian cells.
The M protein encoded by group A streptococci is a cell-wall polypeptide that has the property of enabling these organisms to evade the phagocytic cells of the human host. Therefore, the M protein plays a major role in the pathogenesis of streptococcal diseases. As an initial step toward the use of this protein as a target antigen for the production of prote